A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAF

This publication has 17 references indexed in Scilit:

• Membrane cofactor protein (MCP, CD46) in seminal plasma and on spermatozoa in normal and “sterile” subjects
  European Journal of Immunology, 1993
• Tissue‐specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing
  European Journal of Immunology, 1992
• Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement
  Biochemical Journal, 1992
• Alternative complement pathway-mediated myeloid cell cytotoxicity: Repertoire of membrane factors participating in regulation of C3 deposition and cytolysis
  European Journal of Immunology, 1991
• Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).
  The Journal of Experimental Medicine, 1990
• Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes
  European Journal of Immunology, 1988
• The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
  The Journal of Experimental Medicine, 1987
• Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.
  The Journal of Experimental Medicine, 1987
• Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
  The Journal of Experimental Medicine, 1985
• Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
  The Journal of Experimental Medicine, 1984